SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: Both expressed at low levels in breast cancer

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liu, Huidi ^a,b,c   Mastriani, Emilio ^a   Yan, Zi Qiao ^a   Yin, Si Yuan ^a   Zeng, Zheng ^a   Wang, Hong ^a   Li, Qing Hai ^a   Liu, Hong Yu ^d   Wang, Xiaoyu ^a   Bao, Hong Xia ^a   Zhou, Yu Jie ^a   Kou, Jun Jie ^a   Li, Dongsheng ^a   Li, Ting ^a   Liu, Jianrui ^a,e   Liu, Yongfang ^a   Yin, Lin ^a   Qiu, Li ^a   Gong, Liling ^a   Liu, Shu Lin ^a,b,e  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HMU UCFM Centre for Infection and Genomics   (China)

^c UNIVERSITY OF CALGARY   (Canada)

^d Department of Orthopaedics Surgery   (China)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; AXIN2 PROTEIN, HUMAN; BETA CATENIN; CTNNB1 PROTEIN, HUMAN; SOX7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; WNT PROTEIN;

BREAST TUMOR; CARCINOGENESIS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; METABOLISM; MICROARRAY ANALYSIS; PATHOLOGY; SIGNAL TRANSDUCTION;

AXIN PROTEIN; BETA CATENIN; BREAST NEOPLASMS; CARCINOGENESIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICROARRAY ANALYSIS; SIGNAL TRANSDUCTION; SOXF TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 84969942275     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26136     Document Type: Article

References (51)

1. Kohler, B. A. et al. Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst 107, djv048, doi: 10.1093/jnci/djv048 (2015).
2. Chen, W., Zheng, R., Zeng, H., Zhang, S. & He, J. Annual report on status of cancer in China, 2011. Chin J Cancer Res 27, 2-12 (2015).
3. Ellis, I. O. et al. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20, 479-89 (1992).
4. Eroles, P., Bosch, A., Perez-Fidalgo, J. A. & Lluch, A. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev 38, 698-707 (2012).
5. Di Leo, A. et al. New approaches for improving outcomes in breast cancer in Europe. Breast 24, 321-30 (2015).
6. Sheikh, A. et al. The spectrum of genetic mutations in breast cancer. Asian Pac J Cancer Prev 16, 2177-85 (2015).
7. Johnson, R. W. et al. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer. Clin Exp Metastasis 31, 945-59 (2014).
8. Shrivastava, S., Jeengar, M. K., Reddy, V. S., Reddy, G. B. & Naidu, V. G. Anticancer effect of celastrol on human triple negative breast cancer: Possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways. Exp Mol Pathol 98, 313-327 (2015).
9. Henry, C. et al. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both beta-catenin dependent and independent Wnt signalling. J Cancer Res Clin Oncol 141, 243-54 (2015).
10. Nakareangrit, W., Thiantanawat, A., Visitnonthachai, D., Watcharasit, P. & Satayavivad, J. Sodium arsenite inhibited genomic estrogen signaling but induced pERalpha (Ser118) via MAPK pathway in breast cancer cells. Environ Toxicol doi: 10.1002/tox.22122 (2015).
11. Stovall, D. B., Cao, P. & Sui, G. SOX7: from a developmental regulator to an emerging tumor suppressor. Histol Histopathol 29, 439-45 (2014).
12. Clevers, H. Wnt/beta-catenin signaling in development and disease. Cell 127, 469-80 (2006).
13. Chan, D. W., Mak, C. S., Leung, T. H., Chan, K. K. & Ngan, H. Y. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Oncotarget 3, 1546-56 (2012).
14. Zhou, X. et al. SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells. World J Gastroenterol 17, 4922-7 (2011).
15. Liu, H. et al. Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/beta-catenin signaling pathway. J Ovarian Res 7, 87 (2014).
16. Cui, J. et al. Decreased expression of Sox7 correlates with the upregulation of the Wnt/beta-catenin signaling pathway and the poor survival of gastric cancer patients. Int J Mol Med 34, 197-204 (2014).
17. Li, B. et al. Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients. Pathol Oncol Res 18, 1039-45 (2012).
18. Zhang, Y. et al. SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett 277, 29-37 (2009).
19. Aksoy, I. et al. Sox transcription factors require selective interactions with Oct4 and specific transactivation functions to mediate reprogramming. Stem Cells 31, 2632-46 (2013).
20. Lioubinski, O., Muller, M., Wegner, M. & Sander, M. Expression of Sox transcription factors in the developing mouse pancreas. Dev Dyn 227, 402-8 (2003).
21. Saegusa, M., Hashimura, M. & Kuwata, T. Sox4 functions as a positive regulator of beta-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas. Lab Invest 92, 511-21 (2012).
22. Sinkkonen, S. T. et al. Serial analysis of gene expression in the chicken otocyst. J Assoc Res Otolaryngol 12, 697-710 (2011).
23. Sinner, D. et al. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 27, 7802-15 (2007).
24. Li, S., Wang, C., Liu, X. & Hua, S. The roles of AXIN2 in tumorigenesis and epigenetic regulation. Fam Cancer 14, 325-31 (2014).
25. Liu, D., Li, L., Yang, Y., Liu, W. & Wu, J. The Axin2 rs2240308 polymorphism and susceptibility to lung cancer in a Chinese population. Tumour Biol 35, 10987-91 (2014).
26. Du, P. et al. From disease ontology to disease-ontology lite: statistical methods to adapt a general-purpose ontology for the test of gene-ontology associations. Bioinformatics 25, i63-8 (2009).
27. Shimoda, M. et al. Sox17 plays a substantial role in late-stage differentiation of the extraembryonic endoderm in vitro. J Cell Sci 120, 3859-69 (2007).
28. Nishita, M. et al. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 403, 781-5 (2000).
29. Dennis, G. Jr. et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3 (2003).
30. Antonov, A. V., Schmidt, T., Wang, Y. & Mewes, H. W. ProfCom: a web tool for profiling the complex functionality of gene groups identified from high-throughput data. Nucleic Acids Res 36, W347-51 (2008).
31. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25, 25-9 (2000).
32. Feng, G. et al. A collection of bioconductor methods to visualize gene-list annotations. BMC Res Notes 3, 10 (2010).
33. Osborne, J. D. et al. Annotating the human genome with Disease Ontology. BMC Genomics 10 Suppl 1, S6 doi: 10.1186/1471-2164-10-S1-S6 (2009).
34. Osborne, J. D., Zhu, L. J., Lin, S. M. & Kibbe, W. A. Interpreting microarray results with gene ontology and MeSH. Methods Mol Biol 377, 223-42 (2007).
35. Dasgupta, C. et al. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol 296, L1031-41 (2009).
36. Edlund, S. et al. Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis. Mol Cell Biol 25, 1475-88 (2005).
37. Ekman, M. et al. APC and Smad7 link TGFbeta type I receptors to the microtubule system to promote cell migration. Mol Biol Cell 23, 2109-21 (2012).
38. Wang, C., Guo, Y., Wang, J. & Min, Z. The suppressive role of SOX7 in hepatocarcinogenesis. PLoS One 9, e97433 (2014).
39. Man, C. H. et al. Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia. Blood 125, 3928-36 (2015).
40. Stovall, D. B. et al. The regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol 183, 1645-53 (2013).
41. Fan, R. et al. Methylation of the CpG island near SOX7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome. Tohoku J Exp Med 227, 119-28 (2012).
42. Guo, L. et al. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol Cancer Res 6, 1421-30 (2008).
43. Hayano, T. et al. SOX7 is down-regulated in lung cancer. J Exp Clin Cancer Res 32, 17 (2013).
44. Shen, F. et al. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression. Tumour Biol 36, 1913-21 (2015).
45. Tang, Q. et al. MicroRNA-93 suppress colorectal cancer development via Wnt/beta-catenin pathway downregulating. Tumour Biol 36, 1701-10 (2015).
46. Jia, J. et al. MiR-17-5p modulates osteoblastic differentiation and cell proliferation by targeting SMAD7 in non-traumatic osteonecrosis. Exp Mol Med 46, e107 (2014).
47. DiVito, K. A. et al. Smad7 restricts melanoma invasion by restoring N-cadherin expression and establishing heterotypic cell-cell interactions in vivo. Pigment Cell Melanoma Res 23, 795-808 (2010).
48. Zulehner, G. et al. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence. Am J Pathol 176, 472-81 (2010).
49. Jang, G. B. et al. Blockade of Wnt/beta-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype. Sci Rep 5, 12465, doi: 10.1038/srep12465. (2015).
50. Li, S., Wang, C., Liu, X. & Hua, S. The roles of AXIN2 in tumorigenesis and epigenetic regulation. Fam Cancer 14, 325-31 (2015).
51. Clevers, H. & Nusse, R. Wnt/beta-catenin signaling and disease. Cell 149, 1192-205 (2012).